Skincare Ingredient Science and Derm Studies — 2026-09-10
The FDA-approved UV filter bemotrizinol is officially hitting US shelves, marking the first new sunscreen active ingredient in decades. Meanwhile, new clinical data and market analyses highlight a shift in anti-aging strategies, with peptides and "blue peptides" gaining traction as alternatives or complements to traditional retinoids.
Skincare Ingredient Science and Derm Studies — 2026-09-10
Top developments
Bemotrizinol Sunscreen Filters Debut in US Market
The first products containing bemotrizinol (BEMT), the first new FDA-approved sunscreen filter in over 20 years, are now available for purchase in the United States. The FDA finalized the order in June 2026, allowing BEMT at concentrations up to 6% as a GRASE (Generally Recognized As Safe and Effective) ingredient, with commercial availability beginning August 9, 2026. This development closes a significant gap between US and international sun protection standards, as the ingredient has been widely used in Europe and Asia for decades.
"Blue Peptides" Emerge as Next-Gen Anti-Aging Agents
Korean media reports indicate a rising trend of "blue peptides" positioned as successors to PDRN and retinol in the anti-aging skincare sector. Unlike previous ingredients that focused on external nutrient delivery, these new peptide formulations aim to induce the skin's own regenerative activity. This aligns with broader global search data showing peptides rapidly gaining interest alongside established staples like retinol and vitamin C.
Retinol vs. Peptides: Clinical Efficacy and Consumer Hype
Recent reviews and dermatological discussions continue to scrutinize the efficacy of popular ingredients like retinol and peptides. While retinoids remain the gold standard for photoaging with strong historical clinical support (e.g., tretinoin showing significant improvement in photodamage), newer peptide therapies are being investigated for their collagen-enhancing properties. Dermatologists are advising consumers to distinguish between marketing hype and evidence-backed results, noting that while peptides show promise, retinoids still hold the strongest data for wrinkle reduction.
Antioxidant Market Growth Driven by Ingredient Stability
The global market for cosmetic antioxidants is projected to grow at an annual rate of 6%, reaching $236 million by 2032. These ingredients are increasingly critical for stabilizing formulations against environmental stressors like UV radiation and pollution, reinforcing the importance of antioxidant-rich skincare routines.
Local view
In South Korea, industry publication BioTimes highlights the emergence of "blue peptides" as a key trend, describing a shift from passive ingredient absorption to active stimulation of skin's inherent vitality. Meanwhile, Cosin Korea reports on the expanding role of antioxidants in cosmeceuticals, emphasizing their necessity in protecting skin from environmental damage.
Context & numbers
- Bemotrizinol Concentration: Permitted up to 6% in OTC sunscreens in the US.
- Antioxidant Market: Projected to reach $236 million by 2032, growing at 6% annually.
- Retinoid Efficacy: Historical data continues to support tretinoin's high odds ratio (OR = 4.78) for treating hyperpigmentation compared to other topical interventions.
On the radar
- BEYOND BEAUTY TOKYO 2026: Scheduled for September 30 – October 2, 2026, at Tokyo Big Sight, featuring a focus on next-generation beauty ingredients.
- Dermatology Times Journal Digest: Regular updates on recent studies, including AGA and cardiovascular risk links, continue to inform clinical practice.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
